Emyria (ASX:EMD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Emyria (ASX:EMD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Annual Report
Emyria reports 210% revenue growth and national psychedelic therapy expansion despite $6.1m loss and going concern uncertainty
Appendix 4G and Corporate Governance Statement
Letter to Shareholders - Notice of Annual General Meeting
Notice of Annual General Meeting/Proxy Form
Retirement of Non-Executive Director
Webinar with Former Secretary of Veterans Affairs Dr Shulkin
Notification of cessation of securities - EMD
Emyria Successfully Opens First NSW Empax Clinic
Emyria opens Sydney Empax clinic and begins treating first patients
Application for quotation of securities - EMD
Former US Veterans Affairs Secretary Joins Emyria
Emyria Presentation at FDA Hearing
Emyria presents Australian psychedelic-treatment delivery experience to U.S. FDA
FDA Selects EMD to Present at Psychedelic Medicines Hearing
Emyria selected to address FDA hearing on psychedelic medicines
Emyria Set to Launch First NSW Clinic
Emyria completes key milestones ahead of September Sydney clinic launch
Emyria Year End Presentation for Investor Webinar
Emyria reports strong FY26 growth as psychedelic therapy clinic network expands
Emyria Financial Year-end Update Webinar
Revised Securities Trading Policy
Appendix 4E & Annual Financial Report Year End 30 June 2026
2026 Annual General Meeting - Key Dates
Emyria Unlocks Treatment Capacity
Emyria resolves prescriber bottleneck and recruits therapists to expand Q4 dosing capacity
Notification of cessation of securities - EMD
Change of Registered Office and Principal Place of Business
June 2026 Quarterly Activities Report and Appendix 4C
Emyria expands national clinic network, reports strong revenue growth and positive early depression treatment outcomes
June 2026 Quarterly Investor Webinar
Techknow Invest Roadshow Company Presentation
EMD to Present at Addressing the Mental Health Crisis Event